Christiaan JM Vrints

576 posts

Christiaan JM Vrints banner
Christiaan JM Vrints

Christiaan JM Vrints

@cvrints

Emeritus full professor University of Antwerp Past Chairman dept of Cardiology Antwerp Univ Hospital Past EiC Eur Heart J Acute Cardiovasc Care

Antwerp, Belgium Katılım Mart 2010
371 Takip Edilen729 Takipçiler
Davide Capodanno
Davide Capodanno@DFCapodanno·
#cardioX is more alive than ever. On the same day that @ihtanboga delivers two incredible articles on COBRRA and SELUTION DeNovo, and a masterclass no one interested in biostatistics and trial interpretation should miss, @ehj_ed publishes a debate I joined with @thiele_holger, @cvrints, and others on the significance of the RF-CL model for estimating pre-test probability of coronary artery disease. This article actually originated from the X discussion shown below, where @ihtanboga had also shared a valuable calculator, and I learned a lot from @cvrints as well. These coincidences close the circle. Long live the sparks between scientific literature and social media that keep the debate alive. academic.oup.com/eurheartj/adva…
Davide Capodanno@DFCapodanno

There is one thing that, even as a reviewer and despite having pointed it out during the process, I really haven't understood about the new ESC guidelines for chronic coronary syndromes. Using the new Risk factor-weighted clinical likelihood (RF-CL) model, one can calculate individual risk based on symptoms, sex, and the number of cardiovascular risk factors, and so far so good. In this way, the calculable pre-test probability scores range from 0 to 45%. However, the recommendations for additional diagnostic tests are also applicable to patients with a risk higher than 45%. Now, how does one calculate a pre-test probability higher than 45% based on the RF-CL? With risk enhancers like PAD, resting ECG, etc.? With the calcium score? In fact, the calcium score can be used to determine the new pre-test probability, but I don’t think this is a good reason to perform it on everyone, also because its value lies mainly in recategorizing patients into the very low-risk group when it is zero. However, it seems you cannot determine the new pre-test probability with risk enhancers, unless it is meant that the presence of one of these factors automatically shifts the patient into at least the moderate-risk category. In short, if anyone has figured out how to arrive at the precise number for values above 45%, they’d be doing me a favor, because I can't understand it from the text.

English
5
20
66
16.6K
Christiaan JM Vrints retweetledi
Carlos Collet MD PhD
Carlos Collet MD PhD@ColletCarlos·
The SCAPIS study published in JAMA ~25,000 🇸🇪 participants, ~8 years follow-up. Adding coronary CT angiography #CCTA plaque information improved event prediction beyond clinical risk and calcium score. This is the first study showing the added value of CCTA on top of the calcium score for risk prediction. 🎯 What to look for: lipidic soft (non-calcified) plaque. 👀 Practical takeaway: Consider a CT angiography for risk stratification on top of the calcium score. Link: jamanetwork.com/journals/jama/… 🎥 Posting my avatar summarizing the study.
English
6
55
279
19.9K
Christiaan JM Vrints retweetledi
ACVCPresident
ACVCPresident@ACVCPresident·
Holiday season is at the end and do you know what comes next? The first @escardio congress of the year #ACVC26 TOMORROW is the deadline for late breaking clinical trial submissions - if you have some raw research you still have time until noon CET And don't forget to register for an early fee discount - 7 days left. See you 🔜 in Lisbon. 🇵🇹 escardio.org/Congresses-Eve…
ACVCPresident tweet media
English
1
11
20
2.2K
Carlos Collet MD PhD
Carlos Collet MD PhD@ColletCarlos·
We’re moving at an unprecedented pace in understanding atherosclerosis. The real breakthrough will come from combining morphology + physiology to define lesion-level risk. Our editorial @JACCJournals @crfheart
Carlos Collet MD PhD tweet mediaCarlos Collet MD PhD tweet media
English
4
9
34
1.9K
Christiaan JM Vrints
Christiaan JM Vrints@cvrints·
@DFCapodanno I agree that NSTEMI is challenging and that its long-term outcomes are similar to STEMI. However, isn’t there also a concern about overdiagnosis—and consequently overuse of PCI—because myocardial injury and type II MI are often misinterpreted?
English
0
0
0
18
Davide Capodanno
Davide Capodanno@DFCapodanno·
We always talk about STEMI—and rightly so—but shouldn’t we also focus on NSTEMI? It is no less challenging; in fact, in several respects it is even more complex, as patients are typically older, more often multivessel, and clinically more difficult to manage. This is why this state-of-the-art review on the diagnosis, risk stratification, and early management of non–ST-segment elevation acute coronary syndromes, in my view, deserves careful reading. eurointervention.pcronline.com/article/diagno…
Davide Capodanno tweet media
English
4
33
80
9.3K
Patrick M Looser MD
Patrick M Looser MD@PLooserMD·
@DFCapodanno What is your opinion on the use of aspirin long term (ie after one year) as opposed to clopidogrel?
Patrick M Looser MD tweet media
English
1
0
1
111
Christiaan JM Vrints
Christiaan JM Vrints@cvrints·
@ehj_ed @escardio @ESC_Journals Again, a masterwork from Patrick Serruys, consistently visionary in his forward-looking perspectives on ischemic heart disease management and influential in defining its conceptual future!
English
0
0
2
403
Christiaan JM Vrints
Christiaan JM Vrints@cvrints·
@gbiondizoccai @Medtronic It is not a problem if you do not pull it back into the guiding catheter. It becomes problematic if you cannot advance the stent through the stenosis. Decrimping happened frequently with self-crimped Palmaz-Schatz stents.
English
0
0
1
199
Giuseppe Biondi-Zoccai
Giuseppe Biondi-Zoccai@gbiondizoccai·
Just happened today! Have you ever faced stent decrimping during PCI? How did you manage it? In this case it was a Medtronic Onyx Frontier device @Medtronic
Giuseppe Biondi-Zoccai tweet media
English
25
14
66
13.8K
Davide Capodanno
Davide Capodanno@DFCapodanno·
This study indicates that photon-counting detector computed tomography (PCD-CT) provides high diagnostic accuracy for detecting in-stent restenosis in patients with prior coronary stents. This suggests that PCD-CT may be reliably used to evaluate suspected obstructive coronary artery disease in both stented and unstented coronary segments. eurointervention.pcronline.com/article/photon…
Davide Capodanno tweet media
English
2
22
103
7.6K
Davide Capodanno
Davide Capodanno@DFCapodanno·
We authored this state-of-the-art review, now published in JACC, to provide an updated, comprehensive overview of post–myocardial infarction inflammatory mechanisms and to critically evaluate the emerging clinical evidence on anti-inflammatory therapies for secondary cardiovascular prevention. jacc.org/doi/10.1016/j.…
Davide Capodanno tweet media
English
3
60
167
13.6K
Christiaan JM Vrints retweetledi
Christophe Ponsard
Christophe Ponsard@ChPonsard·
Helemaal akkoord met @prevotmaxime: "“We mogen geen veralgemening maken tussen de joodse gemeenschap, de Israëlische bevolking en het beleid van Netanyahu.” Ik hoopte dat de culturele wereld dit altijd zou begrijpen en verdedigen. nieuwsblad.be/regio/oost-vla…
Nederlands
32
25
225
6.5K